Eckert & Ziegler, DE0005659700

Eckert & Ziegler with a cautious week, shares lag behind healthcare peers

26.06.2026 - 12:57:58 | ad-hoc-news.de

Eckert & Ziegler faces a muted week on Xetra, with the shares trading below some European healthcare peers as analysts keep a cautious stance on the small-cap radiopharma supplier.

Eckert & Ziegler, DE0005659700
Eckert & Ziegler, DE0005659700

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 12:57.

Eckert & Ziegler (DE0005659700) continues to trade on Xetra as a smaller German healthcare name with a focus on nuclear medicine components. The shares reflect a cautious tone this week compared with larger sector peers like Siemens Healthineers and Fresenius Medical Care, according to sector overviews.

How analysts view the shares

On finanzen.net, Eckert & Ziegler shares are quoted at about 15.03 euros, showing a modest decline of around 1.25 percent in recent trading for the EKZRF symbol, underlining the muted sentiment in the name. The stock is typically classified within the healthcare and medical technology space, where larger diversified players such as Siemens Healthineers and Philips often attract more coverage and liquidity in comparison.

The healthcare peer comparison

In the broader European healthcare segment, Siemens Healthineers as part of the DAX and Fresenius Medical Care as a former DAX and current MDAX constituent provide a benchmark for radiology and dialysis-related businesses, with market capitalizations far above Eckert & Ziegler and more extensive analyst followings in reports from houses such as Deutsche Bank and UBS. Sector commentaries regularly highlight that specialized suppliers of radiopharmaceutical components tend to show higher earnings sensitivity to order cycles and regulatory shifts than diversified healthcare equipment giants.

Go deeper

All news and data on Eckert & Ziegler

Further background, price history and corporate disclosures on the Eckert & Ziegler shares are collected in the dedicated topic section and on the company’s Investor Relations pages.

The product behind the stock

Eckert & Ziegler generates most of its revenue with radioisotope-based components and systems that are used for nuclear medicine diagnostics and radiotherapy in hospitals and research centers, as outlined on its corporate pages. These include sealed radiation sources and high-dose rate brachytherapy systems, which are sold to clinics and industry customers under long-term supply agreements in Europe, North America and Asia.

Where the shares trade today

The Eckert & Ziegler shares (DE0005659700) trade primarily on Xetra, with recent indications around 15.03 euros in the latest finanzen.net quote snapshot used here as a sector reference.

Eckert & Ziegler at a glance

  • Company: Eckert & Ziegler AG
  • ISIN: DE0005659700
  • WKN: 565970
  • Ticker: EUZ
  • Trading venue: Xetra
  • Price (as of 2026-06-26, 12:57): 15.03 EUR
  • Market cap: around 0.3 billion EUR (as of 2026-06-26)
  • Sector / industry: Healthcare equipment and services, radiopharmaceuticals
  • Index membership: SDAX
  • Next earnings date: not officially scheduled

More on the Eckert & Ziegler shares in social media

This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. All data are based on sources deemed reliable at the time of publication but may change without notice.

en | DE0005659700 | ECKERT & ZIEGLER | boerse | 69632314 | bgmi